Detalles de la búsqueda
1.
Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy.
J Inherit Metab Dis
; 33(3): 281-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20336375
2.
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Immunology
; 128(2): 260-70, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19740383
3.
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity.
Sci Transl Med
; 11(512)2019 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578241
4.
STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers.
Comp Med
; 61(4): 346-55, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22330250
5.
Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling.
Int J Oncol
; 39(1): 73-89, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21537839
6.
Identification of the chondrocyte lineage using microfibril-associated glycoprotein-2, a novel marker that distinguishes chondrocytes from synovial cells.
Tissue Eng Part C Methods
; 16(6): 1367-75, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20345228
7.
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.
Mol Genet Metab
; 91(3): 259-67, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17509920
8.
AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
J Gene Med
; 8(6): 719-29, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16528760
Resultados
1 -
8
de 8
1
Próxima >
>>